8-K
filed December 23, 2025, 6:59 PM ET
ticker RVPH
CIK 0001742927
regulatory
confidence high
sentiment negative
materiality 0.85
FDA requires second Phase 3 trial for Reviva's brilaroxazine in schizophrenia; NDA delayed to late 2027
REVIVA PHARMACEUTICALS HOLDINGS, INC.
- FDA recommends RECOVER-2 Phase 3 trial (30/50 mg) before NDA submission; similar to RECOVER design.
- RECOVER-2 initiation planned H1 2026, data Q2 2027; NDA target Q4 2027, potential approval Q4 2028; est. cost ~$60M.
- Stockholders approved authorized share increase from 315M to 515M and reverse stock split (1:2 to 1:20, Board discretion).
- Warrant exercises Oct–Dec 2025: 19.8M shares, ~$6.7M net; cash ~$14.7M as of Dec 16, sufficient through Q2 2026 ex-RECOVER-2.
- Long-term safety data from RECOVER open-label extension over 52 weeks shows favorable tolerability and adherence.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-25-038602
- form_type
- 8-K
- ticker
- RVPH
- cik
- 0001742927
- company_name
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at
- 2025-12-23T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:40.313003+00:00
- generated_at
- 2026-05-16T12:16:34.623653+00:00
- sec_items
- ["5.03", "5.07", "7.01", "8.01", "9.01"]
- event_type
- regulatory
- sentiment
- negative
- materiality_score
- 0.85
- calibrated_materiality_score
- 0.85
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-25-038602
- json_url
- https://secwatch.observer/filing/0001437749-25-038602.json
- markdown_url
- https://secwatch.observer/filing/0001437749-25-038602.md
- text_url
- https://secwatch.observer/filing/0001437749-25-038602.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1742927/000143774925038602/0001437749-25-038602-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1742927/000143774925038602/rvph20251216_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
GROO
Groovy dismisses auditor after SEC suspension, reduces authorized common 99.5%, two officers depart
GROOVY COMPANY, INC.
May 28, 2026, 3:28 PM ET
regulatory
Items 4.01, 4.02, 5.03, 5.02, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: regulatory
similar materiality
This filing
On December 18, 2025, the Company filed the Increase in Authorized Charter Amendment with the Secretary of State of the State of Delaware and such amendment became effective immediately.
Comparable filing
On April 14, 2026, Articles of Amendment to the Articles of Incorporation of the Company (the “Articles of Amendment”) became effective upon acceptance for filing by the Secretary of State of the State of Wyoming.
Filing page
SEC filing
SLXN
Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted
Silexion Therapeutics Corp
May 29, 2026, 7:00 AM ET
regulatory
Items 3.03, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
same event type: regulatory
This filing
On December 18, 2025, the Company filed the Increase in Authorized Charter Amendment with the Secretary of State of the State of Delaware and such amendment became effective immediately.
Comparable filing
On May 28, 2026, the Company’s Board of Directors, acting pursuant to that approval by the Company’s shareholders, effected the Reverse Share Split following the close of trading on the Nasdaq Capital Market through the filing of a certificate with the Companies Registry of the Cayman Islands that served as an effective amendment to the Company’s Amended and Restated Memorandum of Association (the “ Memorandum Amendment ”).
Filing page
SEC filing
ESAB
ESAB completes $1.45B acquisition of Eddyfi Technologies
ESAB Corp
June 2, 2026, 6:41 AM ET
m_and_a
Items 2.01, 3.02, 5.03, 3.03, 7.01, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 8.01, 9.01
similar materiality
This filing
On December 18, 2025, the Company filed the Increase in Authorized Charter Amendment with the Secretary of State of the State of Delaware and such amendment became effective immediately.
Comparable filing
On June 1, 2026, the Company filed the Certificate of Designations with the Delaware Secretary of State to establish the preferences, limitations and relative rights of its 6.50% Series A Mandatory Convertible Preferred Stock (the “ Series A Mandatory Convertible Preferred Stock ”), which became effective upon filing.
Filing page
SEC filing
OLOX
Olenox acquires CS Digital for $30M upfront; launches gas-powered data center platform
OLENOX INDUSTRIES INC.
May 28, 2026, 8:30 AM ET
m_and_a
Items 1.01, 5.03, 2.01, 2.03, 3.02, 7.01, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 8.01, 9.01
similar materiality
This filing
On December 18, 2025, the Company filed the Increase in Authorized Charter Amendment with the Secretary of State of the State of Delaware and such amendment became effective immediately.
Comparable filing
On May 26, 2026, in connection with the closing of the Acquisition, the Company filed a Certificate of Designation of Series D Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges and restrictions of the Series D Preferred Stock.
Filing page
SEC filing
SOUN
SoundHound AI files LivePerson financials, pro forma confirming acquisition; $300M equity shelf
SOUNDHOUND AI, INC.
May 27, 2026, 5:27 PM ET
m_and_a
Items 5.03, 5.07, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 8.01, 9.01
similar materiality
This filing
On December 18, 2025, the Company filed the Increase in Authorized Charter Amendment with the Secretary of State of the State of Delaware and such amendment became effective immediately.
Comparable filing
The Second Amended and Restated Bylaws amend and restate those certain Amended and Restated Bylaws of the Company adopted by the Board on April 26, 2022, to remove the provision allowing any unauthorized, defective or conflicted transaction questioned in any stockholders’ derivative suit, or any other suit to enforce alleged rights of the Company or any of its stockholders, to be approved, ratified and confirmed by the Board or the Company’s stockholders before or after judgment, and thereby to be cured, and such approval, ratification or confirmation to constitute a bar to any claim or execution of any judgment in respect of such questioned transaction.
Filing page
SEC filing
Enviri II Corp
New Enviri completes spin-off; starts trading June 2 under NVRI; ~$1.2B revenue, ~$140M EBITDA
Enviri II Corp
June 1, 2026, 5:18 PM ET
m_and_a
Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
similar materiality
This filing
On December 18, 2025, the Company filed the Increase in Authorized Charter Amendment with the Secretary of State of the State of Delaware and such amendment became effective immediately.
Comparable filing
In connection with the Spin-Off, the Board adopted the Code of Conduct, a copy of which is available on New Enviri’s website at www.enviri.com.
Filing page
SEC filing
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
similar materiality
This filing
On December 18, 2025, the Company filed the Increase in Authorized Charter Amendment with the Secretary of State of the State of Delaware and such amendment became effective immediately.
Comparable filing
On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.
Filing page
SEC filing
CECO
CECO Environmental completes acquisition of Thermon Group Holdings, issues ~22.5M shares and pays $329.4M cash
CECO ENVIRONMENTAL CORP
June 1, 2026, 9:16 AM ET
m_and_a
Items 2.01, 2.03, 5.02, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
similar materiality
This filing
On December 18, 2025, the Company filed the Increase in Authorized Charter Amendment with the Secretary of State of the State of Delaware and such amendment became effective immediately.
Comparable filing
The Bylaws Amendment increased the maximum number of directors that may constitute the full Board from nine to ten, to facilitate the expansion of the Board from eight to ten members and the appointment of two directors previously serving on the board of directors of Thermon, as contemplated by the Merger Agreement.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.